And CYR61 was also able to promote breast cancer cell proliferation, cell survival, and Taxol resistance through an alphavbeta3‐activated ERK1/ERK2 MAPK signaling 26 and to confer resistance to mitoxantrone via spleen tyrosine kinase activation in human acute myeloid leukemia 27. This evidence concerns the gene MAPK1 and breast cancer.